PreprintAll rights reservedbioRxiv
Targeting PRMT5 Across Cancers and AI-Driven Discovery of Candidate Compounds
- 1Computational and AI-Driven Drug Discovery Unit, OxUpp BioResearch Center, OxUpp Bangladesh. OxUpp, Stockholm, Sweden. Department of Chemistry, Chemistry Resear
Related
- Integrative genetic and transcriptomic analysis identifies candidate genes and compounds for Fragile X syndrome and autism spectrum disorder
- An ensemble framework for robust drug response prediction and large-scale sensitivity profiling across cancers
- Palmatine as a topical candidate for psoriasis targeting LCK to inhibit NF-κB signaling with computational prediction of Wnt pathway involvement
- Low-molecular-weight Ulva lacinulata extract exhibiting anti-inflammatory and pro-autophagic activities in RAW 264.7 macrophages: a promising candidate for the development of active ingredients targeting low-grade inflammation
- 211 A discovery-to-therapeutics platform for functional antibody targeting of complex membrane-embedded tumor antigens: validation with claudin family members
BibTeX
@misc{rana2026targeting,
title = {{Targeting PRMT5 Across Cancers and AI-Driven Discovery of Candidate Compounds}},
author = {S. Rana and M. S. Hossan and A. A. Rafi and D. D. Hagidok and A. Kumer and M. E. K. Talukder and M. C. Ali and R. A. Al-Amin},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.19.760131},
url = {https://www.biorxiv.org/content/10.64898/2026.10.19.760131v1},
}
RIS
TY - UNPB
TI - Targeting PRMT5 Across Cancers and AI-Driven Discovery of Candidate Compounds
AU - S. Rana
AU - M. S. Hossan
AU - A. A. Rafi
AU - D. D. Hagidok
AU - A. Kumer
AU - M. E. K. Talukder
AU - M. C. Ali
AU - R. A. Al-Amin
PY - 2026
DA - 2026/10/19
PB - bioRxiv
DO - 10.64898/2026.10.19.760131
UR - https://www.biorxiv.org/content/10.64898/2026.10.19.760131v1
ER -